Health Information Portal (HIP)

Carbapenem-Resistant Enterobacterales (CRE)

Topic	Priority Priority Alert Conveys the highest level of importance; warrants immediate action or attention. Advisory Provides important information for a specific incident or situation; may not require immediate action. Notification Provides information regarding an incident or situation; unlikely to require immediate action. Update Provides updated information regarding an incident or situation; unlikely to require immediate action.	Date of Alert
New Carbapenem-Resistant Enterobacteriaceae Warrant Action by Healthcare Providers	Advisory	Apr 8, 2013

Surveillance

• Carbapenem-Resistant Enterobacterales (CRE) Case Definition
• CDC National CRE Tracking

Vaccine Information

There is no vaccine information available for Carbapenem-Resistant Enterobacterales (CRE).

Diagnosis & Management

• CDC Laboratory Resources for HAIs
• CDC CRE Information for Health Professionals

Resources

For Healthcare Providers:

Reporting to PDPH

Report CRE cases to the Philadelphia Department of Public Health by calling 215-685-6748 during business hours or completing and faxing the CRE Patient Report Form below to 215-238-6947

• PDPH CRE Patient Report Form
• PDPH FAQ: New Drug-Resistant Organism Reporting Requirements in Philadelphia

Health Educational Materials

• PDPH CRE Fact Sheet

CRE Guidelines

Healthcare Facilities

• PDPH Inter-Facility Transfer Form
• PDPH Long Term Care Facility Checklist
• PDPH Line List

Links & Resources

• PDPH Infection Prevention Symposium: Antimicrobial Stewardship and Carbapenem-Resistant Enterobacteriaceae [PDPH, 2014]
• CDC Threat Report: Antibiotic Resistance Threats in the United States [CDC, 2019]
• CDC Vital Signs Report: Carbapenem-Resistant Enterobacteriaceae [MMWR, March 8, 2013 / 62(09);165-170]

For Patients and Community Members:

Posters:

There are no posters for Carbapenem-Resistant Enterobacterales (CRE).